Liquidia Corp. (LQDA)
38.14
-1.07
(-2.73%)
USD |
NASDAQ |
May 01, 16:00
40.21
+2.07
(+5.43%)
After-Hours: 20:00
Liquidia EPS Diluted (Quarterly) : 0.1455 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.172 |
| ADMA Biologics, Inc. | 0.2025 |
| Lexicon Pharmaceuticals, Inc. | -0.0427 |
| aTyr Pharma, Inc. | -0.1425 |
| Kura Oncology, Inc. | -0.9199 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 14.56M |
| Revenue (Quarterly) | 92.02M |
| Total Expenses (Quarterly) | 77.47M |
| Enterprise Value | 3.398B |
| Gross Profit Margin (Quarterly) | 92.09% |
| Profit Margin (Quarterly) | 15.82% |
| Earnings Yield | -2.18% |
| Normalized Earnings Yield | -2.181 |